Extended-release exenatide (Bydureon BCise), given weekly, uses a microsphere suspension that may cause more injection site nodules (reported in 10.5% of patients according to its FDA label) compared to solution-based formulations
CI 77891, Propylene Glycol, Citric Acid, Carica Papaya (Papaya) Fruit Extract, Kojic Acid, Alpha-arbutin, Dimethicone, Sodium Cocoate, Sucrose, Sodium Benzoate, CI 15850
However, the absence of reported interactions does not constitute proof of safety in all contexts, especially for individuals with hepatic impairment, renal disease, or concurrent medications that affect glucose metabolism
The call is delivered as a single note, sometimes repeated in a short series that drops slightly in pitch and volume from beginning to end
Thalassemia major patients using iron chelators showed a reduced plasma thioredoxin level and reduced thioredoxin reductase activity, despite elevated oxidative stress
At 0.2 mg per unit, 25 units = 5 mg